{"id":504,"date":"2011-11-19T10:44:54","date_gmt":"2011-11-19T14:44:54","guid":{"rendered":"http:\/\/blogviejo.sld.cu\/oserranob\/?p=504"},"modified":"2011-11-19T10:44:54","modified_gmt":"2011-11-19T14:44:54","slug":"nuevo-tratamiento-para-linfoma-folicular","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2011\/11\/19\/nuevo-tratamiento-para-linfoma-folicular\/","title":{"rendered":"Nuevo tratamiento para linfoma folicular"},"content":{"rendered":"<p>El an\u00e1lisis bioinform\u00e1tico de los datos gen\u00f3micos disponibles sobre el <a title=\"Informaci\u00f3n sobre la enfermedad\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/omim\/613024\" target=\"_blank\"><strong>linfoma folicular<\/strong><\/a> condujo a la identificaci\u00f3n de la prote\u00edna <strong><a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/2045\" target=\"_blank\">EPHA7<\/a> <\/strong>(del ingl\u00e9s <em>ephrin receptor A7<\/em>) como una nueva diana terap\u00e9utica para la enfermedad dada su actividad antitumoral. La administraci\u00f3n en ratones de <strong><a title=\"Informaci\u00f3n sobre el gen\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/gene\/2045\" target=\"_blank\">EPHA7<\/a> <\/strong>fusionada con anticuerpos espec\u00edficos redujo el tama\u00f1o de los tumores, de acuerdo con el reporte en <a title=\"Resumen en ingl\u00e9s\" href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0092867411011469?_rdoc=13&amp;_fmt=high&amp;_origin=browse&amp;_srch=hubEid(1-s2.0-S0092867411X00223)&amp;_docanchor=&amp;_ct=26&amp;_refLink=Y&amp;_zone=rslt_list_item&amp;md5=05c58ab89ee3a8885cf6a3363565def9\" target=\"_blank\"><strong>Cell<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El an\u00e1lisis bioinform\u00e1tico de los datos gen\u00f3micos disponibles sobre el linfoma folicular condujo a la identificaci\u00f3n de la prote\u00edna EPHA7 (del ingl\u00e9s ephrin receptor A7) como una nueva diana terap\u00e9utica para la enfermedad dada su actividad antitumoral. La administraci\u00f3n en ratones de EPHA7 fusionada con anticuerpos espec\u00edficos redujo el tama\u00f1o de los tumores, de acuerdo [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11,15,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/504"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=504"}],"version-history":[{"count":0,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/504\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}